Most Recent

image: Upheaval Over Children’s Health Study

Upheaval Over Children’s Health Study

By | March 21, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

0 Comments

image: Prometheus Patents Overturned

Prometheus Patents Overturned

By | March 20, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

12 Comments

image: Teaching HIV/AIDS Denialism?

Teaching HIV/AIDS Denialism?

By | March 20, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

16 Comments

image: New African Bone Marrow Registry

New African Bone Marrow Registry

By | March 19, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

0 Comments

image: Immune Role in Brain Disorder?

Immune Role in Brain Disorder?

By | March 19, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

2 Comments

image: HHMI Competition Opens

HHMI Competition Opens

By | March 16, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

0 Comments

image: Trouble at the CDC?

Trouble at the CDC?

By | March 12, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

4 Comments

image: High Tumor Heterogeneity Confirmed

High Tumor Heterogeneity Confirmed

By | March 9, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

2 Comments

image: Origami Sensors

Origami Sensors

By | March 9, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

2 Comments

image: Transplant Without Drugs?

Transplant Without Drugs?

By | March 8, 2012

A second advisor for the National Children’s Study resigns in response to changes in study design.

6 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech